期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Insight to Pyroptosis in Viral Infectious Diseases 被引量:2
1
作者 Junxia Li Lijun Chen +6 位作者 Changhui Zhou Yifan Bai Ruiyan Zhao jinge zhang Xiaoqiao Xu Xingyi Ge Ye Qiu 《Health》 2021年第5期574-590,共17页
<strong>Background: </strong>Pyroptosis is defined as programmed necrosis executed by gasdermin D or E (GSDMD or GSDME), which punches cellular membrane. Morphologically, pyroptosis is characterized by cel... <strong>Background: </strong>Pyroptosis is defined as programmed necrosis executed by gasdermin D or E (GSDMD or GSDME), which punches cellular membrane. Morphologically, pyroptosis is characterized by cell swelling and cell membrane rupture, leading to the release of cellular contents that triggers intense inflammatory response. More and more studies have found that pyroptosis may be involved in the pathogenesis of viral infection, which may be a determinant for inflammation observed in most viral diseases. <strong>Objective:</strong> This paper aims to summarize the roles of pyroptosis in the pathogenesis of viral infectious diseases and to provide potential drug targets for the treatment of viral diseases, which will contribute to medical research and public health. <strong>Measures:</strong> This paper mainly summarizes pyroptosis occurring in diseases caused by different viruses, including human immunodeficiency virus, hepatitis virus, enterovirus, influenza virus and dengue fever virus. Meanwhile, the reported mechanism underlying pyroptosis mediating pathogenesis of these viral diseases will also be described. <strong>Conclusion:</strong> Current studies have shown that pyroptosis is a double-edged sword in viral infectious diseases. On one hand, pyroptosis leads to pathogenic inflammation of many viral infectious diseases which aggravate tissue damage initiated by viral infection, and blocking proptosis usually relieves the inflammation, which exerts therapeutic effects on viral diseases. On the other hand, moderating pyroptosis can contribute to defense against pathogen infection by releasing immune epitopes and inducing antiviral immune response. 展开更多
关键词 PYROPTOSIS Viral Infectious Diseases Gasdermin D Gasdermin E CASPASE INFLAMMATION
下载PDF
恶性血液病患者化疗后出血与血小板计数和白细胞计数的关系 被引量:13
2
作者 徐金格 陈令松 +3 位作者 张秋荣 张桂华 刘凯歌 吴进燕 《中国输血杂志》 CAS 北大核心 2017年第1期40-42,共3页
目的探讨恶性血液病患者化疗后出血的与白细胞和血小板计数的关系。方法观察96例恶性血液病化疗后的临床出血情况,监测出血时血小板计数、化疗前白细胞计数。比较不同年龄组、性别、疾病缓解状态的出血发生率;分析出血程度与血小板减少... 目的探讨恶性血液病患者化疗后出血的与白细胞和血小板计数的关系。方法观察96例恶性血液病化疗后的临床出血情况,监测出血时血小板计数、化疗前白细胞计数。比较不同年龄组、性别、疾病缓解状态的出血发生率;分析出血程度与血小板减少程度、白细胞计数的关系。结果 96例恶性血液病患者化疗后出血28例(ALL4例,AML(非M3型)16例,NHL1例,MM2例,HL1例,MDS4例),出血发生率为29.2%;≥55岁组出血发生率为44.2%(23/52),明显高于<55岁组(11.4%,5/44)(χ~2=12.462,P<0.05),而不同性别患者化疗后出血发生率的差异无统计学意义(P>0.05)。缓解组患者化疗后出血发生率为15.21%;未缓解组患者出血发生率为42.0%,较缓解组患者出血发生率高(χ~2=8.318,P<0.05)。出血患者均有血小板减少,1-2级出血组和3-4级出血组患者的血小板减少程度的差异有统计学意义(χ~2=13.38,P<0.01)。白细胞计数≥50×109/L的急性白血病患者出血患者3-4级的出血发生率高于白细胞计数<50×109/L的患者,差异有统计学意义(χ~2=6.806,P<0.05)。结论年龄≥55岁、恶性血液病未缓解可能为出血的危险因素;白细胞计数≥50×109/L可能为急性白血病患者3-4级出血的危险因素;血小板减少与恶性血液病患者出血相关,血小板<20×109/L时出血发生率明显增加。 展开更多
关键词 恶性血液病 出血 危险因素
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部